Tag Archives: From

Novartis C.E.O. Defends Company’s Decision to Withhold False Data From the F.D.A.

The chief executive of Novartis on Wednesday defended the company’s decision to delay telling the Food and Drug Administration about manipulated data involving its $ 2.1 million gene therapy treatment, saying that it “thoroughly, aggressively” investigated the issue and that patient safety was never threatened. Vas Narasimhan, the chief executive, also indicated in a call… Read More »

Man who died allegedly after eating gecko on dare had ‘rotted from inside,’ family says

An Australian family is still grieving over the unexpected loss of their father, who fell gravely ill allegedly after eating a gecko on a dare. David Dowell was reportedly challenged to eat the small lizard at a Christmas party last year, and was rushed to the hospital two days later in “absolute agony.” “It was a dare… Read More »

Digital therapeutics in demand, but support needed from payers

Digital therapeutics can be used to prevent, manage or treat diseases—particularly chronic conditions—but their widespread use is stalled for lack of reimbursement from private and public payers. According to a new study by data and analytics company GlobalData, entitled, “Digital Therapeutics and Their Impact on Healthcare,” there is a growing number of digital therapeutics (DTx)… Read More »